79 related articles for article (PubMed ID: 25379720)
1. Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data.
Kim IW; Han N; Kim MG; Kim T; Oh JM
Pharmacogenet Genomics; 2015 Jan; 25(1):1-7. PubMed ID: 25379720
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
3. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
4. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C
Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of PHF6 gene in T-cell acute lymphoblatic leukemia, acute myelogenous leukemia and hepatocellular carcinoma.
Yoo NJ; Kim YR; Lee SH
Acta Oncol; 2012 Jan; 51(1):107-11. PubMed ID: 21736506
[TBL] [Abstract][Full Text] [Related]
6. [Identification of the regions of copy number amplification associated with hepatocellular carcinoma].
Zhang SG; Gao YT; Song WQ; Du Z; Yang B; Wang YJ; Zhu ZY
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):566-70. PubMed ID: 20021941
[TBL] [Abstract][Full Text] [Related]
7. Copy number variants in pharmacogenetic genes.
He Y; Hoskins JM; McLeod HL
Trends Mol Med; 2011 May; 17(5):244-51. PubMed ID: 21388883
[TBL] [Abstract][Full Text] [Related]
8. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
9. Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans.
Han N; Oh JM; Kim IW
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33430289
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
Qiu ZW; Bi JH; Gazdar AF; Song K
Genes Chromosomes Cancer; 2017 Jul; 56(7):559-569. PubMed ID: 28379620
[TBL] [Abstract][Full Text] [Related]
11. The limits of genome-wide methods for pharmacogenomic testing.
Gamazon ER; Skol AD; Perera MA
Pharmacogenet Genomics; 2012 Apr; 22(4):261-72. PubMed ID: 22344246
[TBL] [Abstract][Full Text] [Related]
12. Copy number variations and human genetic disease.
Mikhail FM
Curr Opin Pediatr; 2014 Dec; 26(6):646-52. PubMed ID: 25198053
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma].
Yu YC; Sun FY; Li Z; Lu SY; Teng XH
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
15. Implications of gene copy-number variation in health and diseases.
Almal SH; Padh H
J Hum Genet; 2012 Jan; 57(1):6-13. PubMed ID: 21956041
[TBL] [Abstract][Full Text] [Related]
16. Genomic copy number variations: A breakthrough in our knowledge on schizophrenia etiology?
Hosak L; Silhan P; Hosakova J
Neuro Endocrinol Lett; 2012; 33(2):183-90. PubMed ID: 22592199
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.
Araujo AN; Moraes L; França MI; Hakonarson H; Li J; Pellegrino R; Maciel RM; Cerutti JM
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1104-12. PubMed ID: 24601688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
